Literature DB >> 14692042

Hypersensitivity and idiosyncratic reactions to oxaliplatin.

Pankaj Bhargava, David Gammon, Michael J McCormick.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14692042     DOI: 10.1002/cncr.11901

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  10 in total

Review 1.  Severe anaphylactic reactions in patients receiving oxaliplatin therapy: a rare but potentially fatal complication.

Authors:  Ming-Yang Lee; Muh-Hwa Yang; Jin-Hwang Liu; Chueh-Chuan Yen; Pang-Chan Lin; Hao-Wei Teng; Wei-Shu Wang; Tzeon-Jye Chiou; Po-Min Chen
Journal:  Support Care Cancer       Date:  2006-07-25       Impact factor: 3.603

2.  Fever as the only manifestation of hypersensitivity reactions associated with oxaliplatin in a patient with colorectal cancer Oxaliplatin-induced hypersensitivity reaction.

Authors:  M Wasif Saif; Shailja Roy; Leslie Ledbetter; Jennifer Madison; Kostas Syrigos
Journal:  World J Gastroenterol       Date:  2007-10-21       Impact factor: 5.742

3.  Hypersensitivity reactions associated with platinum antineoplastic agents: a systematic review.

Authors:  Nektaria Makrilia; Ekaterini Syrigou; Ioannis Kaklamanos; Leonidas Manolopoulos; Muhammad Wasif Saif
Journal:  Met Based Drugs       Date:  2010-09-20

4.  Management of hypersensitivity to platinum- and taxane-based chemotherapy: cepo review and clinical recommendations.

Authors:  J Boulanger; J N Boursiquot; G Cournoyer; J Lemieux; M S Masse; K Almanric; M P Guay
Journal:  Curr Oncol       Date:  2014-08       Impact factor: 3.677

Review 5.  Hypersensitivity reactions to oxaliplatin and other antineoplastic agents.

Authors:  Ekaterini Syrigou; Kostas Syrigos; M Wasif Saif
Journal:  Curr Allergy Asthma Rep       Date:  2008-03       Impact factor: 4.806

6.  Tolerance and activity of oxaliplatin with protracted topotecan infusion in patients with previously treated ovarian cancer. A phase I study.

Authors:  Howard Hochster; Thomas T Chen; Janice M Lu; Day Hills; Joan Sorich; Juliet Escalon; Percy Ivy; Leonard Liebes; Franco Muggia
Journal:  Gynecol Oncol       Date:  2008-01-11       Impact factor: 5.482

Review 7.  Oxaliplatin-induced severe anaphylactic reactions in metastatic colorectal cancer: case series analysis.

Authors:  Jui-Ho Wang; Tai-Ming King; Min-Chi Chang; Chao-Wen Hsu
Journal:  World J Gastroenterol       Date:  2012-10-14       Impact factor: 5.742

Review 8.  Drug Desensitizations for Chemotherapy: Safety and Efficacy in Preventing Anaphylaxis.

Authors:  Joana Caiado; Mariana C Castells
Journal:  Curr Allergy Asthma Rep       Date:  2021-07-07       Impact factor: 4.806

9.  Effectiveness of oxaliplatin desensitization protocols.

Authors:  Susana Cortijo-Cascajares; Inmaculada Nacle-López; Ignacio García-Escobar; María José Aguilella-Vizcaíno; Alberto Herreros-de-Tejada; Hernán Cortés-Funes Castro; Miguel-Ángel Calleja-Hernández
Journal:  Clin Transl Oncol       Date:  2012-07-25       Impact factor: 3.405

10.  A single-arm Phase II validation study of preventing oxaliplatin-induced hypersensitivity reactions by dexamethasone: the AVOID trial.

Authors:  Yoichiro Yoshida; Keiji Hirata; Hiroshi Matsuoka; Shigeyoshi Iwamoto; Masahito Kotaka; Hideto Fujita; Naoya Aisu; Seiichiro Hoshino; Takeo Kosaka; Kotaro Maeda; Fumiaki Kiyomi; Yuichi Yamashita
Journal:  Drug Des Devel Ther       Date:  2015-11-11       Impact factor: 4.162

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.